Berman Capital Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$8K Hold
134
﹤0.01% 1243
2021
Q2
$8K Hold
134
﹤0.01% 1183
2021
Q1
$6K Hold
134
﹤0.01% 1194
2020
Q4
$5K Buy
134
+93
+227% +$3.06K ﹤0.01% 1124
2020
Q3
$1K Hold
41
﹤0.01% 1400
2020
Q2
$1K Hold
41
﹤0.01% 1371
2020
Q1
$1K Hold
41
﹤0.01% 1240
2019
Q4
$1K Hold
41
﹤0.01% 1294
2019
Q3
$1K Hold
41
﹤0.01% 1281
2019
Q2
$1K Hold
41
﹤0.01% 1297
2019
Q1
$1K Hold
41
﹤0.01% 1174
2018
Q4
$1K Buy
+41
New +$1.6K ﹤0.01% 947

Other funds holding ATEX

Berman Capital Advisors's ATEX Position: Q3 2021 in Review

Berman Capital Advisors held its Anterix (ATEX) position steady in Q3 2021 at 134 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Berman Capital Advisors first reported a position in ATEX in Q4 2018 and has held it in 12 quarters since. 106 funds tracked by Wall St. Rank hold ATEX as of Q3 2021.

  • Berman Capital Advisors held 134 shares of Anterix worth $8K as of Q3 2021.
  • Berman Capital Advisors left its Anterix share count unchanged in Q3 2021.
  • Anterix made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1243 holding.
  • Berman Capital Advisors first reported a position in Anterix in Q4 2018 and has held it in 12 quarters since.
  • 106 funds tracked by Wall St. Rank held Anterix as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.